Lipocalin 2 enhances mesenchymal stem cell-based cell therapy in acute kidney injury rat model

Acute kidney injury (AKI) is one of the most common health-threatening diseases in the world. There is still no effective medical treatment for AKI. Recently, Mesenchymal stem cell (MSC)-based therapy has been proposed for treatment of AKI. However, the microenvironment of damaged kidney tissue is n...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cytotechnology
Autors principals: Roudkenar, Mehryar Habibi, Halabian, Raheleh, Tehrani, Hossein Abdul, Amiri, Fatemeh, Jahanian-Najafabadi, Ali, Roushandeh, Amaneh Mohammadi, Abbasi-Malati, Zahra, kuwahara, Yoshikazu
Format: Artigo
Idioma:Inglês
Publicat: Springer Netherlands 2017
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5809639/
https://ncbi.nlm.nih.gov/pubmed/28573544
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10616-017-0107-2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars